<DOC>
	<DOCNO>NCT00883259</DOCNO>
	<brief_summary>Gestational diabetes mellitus ( DM ) one frequent complication pregnant patient polycystic ovary syndrome ( PCOS ) 20-40 % case ~40 % patient gestational DM likely underlying polycystic ovarian morphology . A recent meta-analysis demonstrate significantly high risk develop gestational DM [ odds ratio ( OR ) 2.94 ; 95 % confidence interval ( CI ) : 1.70-5.08 ] PCOS population . Metformin oral biguanide insulin sensitizer use treat type-2 DM recently introduce treat PCOS . At moment , preliminary data seem reassure regard use metformin PCOS patient show benefit maternal fetal outcome , without serious adverse event . Furthermore , well-designed randomized , control trial ( RCTs ) issue lack , thus possible either suggest advice use metformin pregnancy reduce gestational DM risk . To regard , PCOS represent intriguing model `` high-risk patient '' evaluate efficacy metformin prevent DM development . The present protocol firstly evaluate effect metformin administration reduce incidence gestational DM high-risk patient , pregnant PCOS patient .</brief_summary>
	<brief_title>Metformin Gestational Diabetes High-risk Patients : RCTs</brief_title>
	<detailed_description>Obese pregnant PCOS patient previous diagnosis gestational DM enrol allocate two treatment arm ( experimental placebo group ) . Subjects experimental group receive metformin dosage 850 mg twice daily , whereas subject control group receive placebo tablet ( microcristallyne cellulose ) twice daily . At baseline , subject undergo clinical evaluation , serial ultrasound examination , venous blood draw evaluate complete hormonal assay serum fast glucose insulin level . The homeostasis model assessment-insulin resistance , fast glucose-to-insulin ratio , free androgen index also calculate . Monthly follow-up visit perform assess maternal fetal wellbeing . The primary endpoint study incidence gestational DM . The power analysis sample size calculation , perform use SamplePower release 2.0 , show need enroll least 40 patient group yield statistically significant result power study 90 % . For categorical variable , Pearson chi-square test perform . Continuous data express either mean standard deviation median inter-quartile range min-max value , accord normal distribution , analyse use Student test Mann-Whitney U test , respectively . Statistical significance set P &lt; 0.05 . The Statistics Package Social Science ( SPSS 14.0.1 ; Chicago , IL , USA ) use statistical analysis .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Pregnant woman Polycystic Ovary Syndrome ( use ASRM/ESHRE criterion ) BMI &gt; 30 Previous diagnosis gestational DM Major medical condition Organic pelvic diseases Previous pelvic surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>High-risk patient</keyword>
	<keyword>Metformin</keyword>
	<keyword>PCOS</keyword>
	<keyword>Pregnancy complication</keyword>
	<keyword>Previous gestational DM</keyword>
</DOC>